CAS 114870-03-0: Fondaparinux
Formula:C31H53N3O49S8·10Na
InChI:InChI=1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-;;;;;;;;;;/m1........../s1
InChI key:InChIKey=XNHJPDRIKNIMPQ-JASSWCPGSA-N
SMILES:O([C@H]1[C@H](OS(=O)(=O)O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@@H]2[C@H](C(O)=O)O[C@@H](O[C@@H]3[C@@H](COS(=O)(=O)O)O[C@H](OC)[C@H](NS(=O)(=O)O)[C@H]3O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@@H]1COS(=O)(=O)O)[C@@H]4O[C@H](C(O)=O)[C@@H](O[C@@H]5[C@H](NS(=O)(=O)O)[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O5)[C@H](O)[C@H]4O.[Na]
Synonyms:- IC 851589
- SR 90107A
- α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10)
- Fondaparinux sodium
- α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), decasodium salt
Sort by
Found 13 products.
Fondaparinux sodium
CAS:Fondaparinux sodium is an anticoagulant, which is a synthetic pentasaccharide based on the antithrombin-binding sequence of heparin. As a meticulously engineered compound, it is derived by chemical synthesis. Its mode of action involves the selective inhibition of factor Xa, a critical enzyme in the coagulation cascade. By binding specifically to antithrombin III, it enhances the inactivation of factor Xa, thereby interrupting the pathway that leads to thrombin formation and ultimately preventing fibrin clot formation. Fondaparinux sodium is primarily used for the prophylaxis of deep vein thrombosis (DVT) in patients undergoing surgery, such as orthopedic procedures involving the hip and knee. Additionally, it is utilized for the treatment of acute pulmonary embolism and DVT in certain patients, where it aids in minimizing the risk of blood clots. Importantly, its action results in a predictable anticoagulant effect, reducing the need for frequent monitoring, which marks a significant advantage over some traditional anticoagulants.Formula:C31H43N3Na10O49S8Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:1,728.09 g/molα-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10)
CAS:Formula:C31H43N3Na10O49S8Purity:98%Color and Shape:SolidMolecular weight:1728.0815Fondaparinux Sodium System Suitability Mixture A Solution
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C31H43N3O49S8Na10(majorcomponent)Color and Shape:LiquidMolecular weight:1726.77078Fondaparinux Sodium Salt
CAS:Formula:C31H43N3O49S8·10NaColor and Shape:White To Off-White SolidMolecular weight:1498.14 10*22.99Fondaparinux sodium
CAS:Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity.Formula:C31H44N3Na10O49S8Purity:100.00% - ≥98%Color and Shape:SolidMolecular weight:1729.09Fondaparinux Sodium System Suitability Mixture B Solution
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C31H43N3O49S8Na10(majorcomponent)Molecular weight:1726.77078Fondaparinux Sodium Identification
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only nesoiFormula:C31H43N3Na10O49S8Color and Shape:White Off-White PowderMolecular weight:1726.77078Fondaparinux Sodium System Suitability Mixture B (A mixture containing fondaparinux sodium and fondaparinux related compound A, B, C, D, E, F, and G)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C31H43N3O49S8Na10Color and Shape:White PowderMolecular weight:1726.77078Fondaparinux Sodium for Assay
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only nesoiFormula:C31H43N3O49S8Na10Color and Shape:Clear Colorless LiquidMolecular weight:1726.77078Fondaparinux Sodium
CAS:Controlled ProductApplications Synthetic pentasaccharide corresponding to the anti-thrombin binding site of heparin. Anti-thrombotic. References Herbert, J.M., et al.: Cardiovasc. Drug Rev., 15, 1 (1997), Turpie, A.G.G., et al.: Expert Opin. Drug Saf., 4, 707 (2005),Formula:C31H43N3O49S8·10NaColor and Shape:White SolidMolecular weight:1728.08Fondaparinux Sodium Impurity 14
CAS:Formula:C31H42N3NaO52S9·11NaColor and Shape:White To Off-White SolidMolecular weight:1600.18 11*22.99
